These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 22759932)
21. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine. de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345 [TBL] [Abstract][Full Text] [Related]
22. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia]. Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343 [TBL] [Abstract][Full Text] [Related]
23. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China. Li ZJ; Guo ZH; Wang N; Xu ZY; Qu Y; Wang XQ; Sun J; Yan LQ; Ng RM; Turkington D; Kingdon D Psychol Med; 2015 Jul; 45(9):1893-905. PubMed ID: 25532460 [TBL] [Abstract][Full Text] [Related]
24. Preliminary evaluation of culturally adapted CBT for psychosis (CA-CBTp): findings from developing culturally-sensitive CBT project (DCCP). Habib N; Dawood S; Kingdon D; Naeem F Behav Cogn Psychother; 2015 Mar; 43(2):200-8. PubMed ID: 24382109 [TBL] [Abstract][Full Text] [Related]
25. Cognitive Behavioral Therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study. Staring AB; Ter Huurne MA; van der Gaag M J Behav Ther Exp Psychiatry; 2013 Sep; 44(3):300-6. PubMed ID: 23454550 [TBL] [Abstract][Full Text] [Related]
26. Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment. Klingberg S; Wittorf A; Herrlich J; Wiedemann G; Meisner C; Buchkremer G; Frommann N; Wölwer W Eur Arch Psychiatry Clin Neurosci; 2009 Nov; 259 Suppl 2():S149-54. PubMed ID: 19876673 [TBL] [Abstract][Full Text] [Related]
27. Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Hjorthøj CR; Fohlmann A; Larsen AM; Gluud C; Arendt M; Nordentoft M Psychol Med; 2013 Jul; 43(7):1499-510. PubMed ID: 23040144 [TBL] [Abstract][Full Text] [Related]
28. Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia. Carbon M; Correll CU CNS Spectr; 2014 Dec; 19 Suppl 1():38-52; quiz 35-7, 53. PubMed ID: 25403863 [TBL] [Abstract][Full Text] [Related]
29. Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Klingberg S; Wölwer W; Engel C; Wittorf A; Herrlich J; Meisner C; Buchkremer G; Wiedemann G Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S98-110. PubMed ID: 21860053 [TBL] [Abstract][Full Text] [Related]
30. Cognitive behavioral therapy for schizophrenia: an empirical review. Rector NA; Beck AT J Nerv Ment Dis; 2001 May; 189(5):278-87. PubMed ID: 11379970 [TBL] [Abstract][Full Text] [Related]
31. Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial. Valmaggia LR; van der Gaag M; Tarrier N; Pijnenborg M; Slooff CJ Br J Psychiatry; 2005 Apr; 186():324-30. PubMed ID: 15802690 [TBL] [Abstract][Full Text] [Related]
32. Cognitive-behavioral therapy for schizophrenia: a review. Turkington D; Dudley R; Warman DM; Beck AT J Psychiatr Pract; 2004 Jan; 10(1):5-16. PubMed ID: 15334983 [TBL] [Abstract][Full Text] [Related]
35. A Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for Schizophrenia. Radhakrishnan R; Kiluk BD; Tsai J Psychiatr Q; 2016 Mar; 87(1):57-62. PubMed ID: 25952944 [TBL] [Abstract][Full Text] [Related]
36. It is all in the factors: effects of cognitive remediation on symptom dimensions. Cella M; Reeder C; Wykes T Schizophr Res; 2014 Jun; 156(1):60-2. PubMed ID: 24768130 [TBL] [Abstract][Full Text] [Related]